Scrip is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Althera Medical Ltd.

Latest From Althera Medical Ltd.

Althera Medical Ltd.

Alpha particle therapy is emerging as a potentially powerful weapon in the fight against cancer, but the short range of these heavy particles has limited their investigational use to date to blood cancers. Israel's Althera Medical Ltd. has found a way to deliver them into solid tumors: Its DART technology uses radioactive wires inserted in tumors to trigger a recoil mechanism that sends high-energy alpha particles throughout the mass, breaking cells' DNA and eventually eradicating the tumor.
Medical Device

Start-Up Previews (12/06)

A preview of the emerging health care companies profiled in the current issue of Start-Up. This month's profile group, "Next-Generation Sequencing" includes profiles of BioNanomatrix, LaserGen, and Microchip Biotechnologies. Plus these Start-Ups Across Health Care: Althera, Impliant, Tenaxis, and VIDA Diagnostics.
See All

Company Information

  • Industry
  • Medical Devices
    • Radiofrequency Devices
  • Therapeutic Areas
  • Cancer
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Middle East
      • Israel
  • Parent & Subsidiaries
  • Althera Medical Ltd.
  • Senior Management
  • Gideon Shichman, CEO
  • Contact Info
  • Althera Medical Ltd.
    Phone: (972) 3 6486687
    6 Anatot St.
    Tel Aviv,